The Innovation in Pediatric Drugs Act of 2025 aims to enhance the development and availability of medications for pediatric patients, particularly those suffering from cancer. The legislation focuses on improving the processes for conducting pediatric drug studies to ensure that children have access to safe and effective treatments. Key provisions include increased accountability for pharmaceutical companies regarding their obligations to conduct pediatric studies. The U.S.